DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update

BY admin admin

<p>Now seeking out license opportunities for SYMJEPI® SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) &#8212; DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders, today announced that it is reacquiring the rights to its SYMJEPI® (epinephrine) Injection [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/dmk-pharmaceuticals-regains-full-rights-from-us-worldmeds-for-symjepi-and-provides-corporate-update/">DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Forex

Record Year for Spectrum with 1.62 Billion Securities Traded

<p>Despite difficult market conditions, the pan-European trading venue for securities, Spectrum Markets, has achieved a new volume record in 2023. According to the company’s latest report, the t

Forex

As China's economy starts to recover its going to be a hard fiscal road for the government

Revenue for Chinese governments (central and local) has dropped 9.9% y/y (in January and February combined) following the economic shut down. – biggest fall since February 2009 There was some of

Forex

The NZD is the strongest and the USD is the weakest as NA trader enter for the day

Risk on is on Risk on.&nbsp;&nbsp; All the chips are being pushed in as the world economy reopens and that has the &quot;risk on&quot; flows in full force.&nbsp; The NZD and AUD ar

Copyright © 2024 | WordPress Theme: Xews Lite